Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Neurology

Symptoms and Warning Signs of Paraneoplastic Polyneuropathy

At a Glance

Paraneoplastic polyneuropathy often worsens over weeks to months, causing patchy sensory loss, burning pain, balance problems, weakness, or changes in automatic body functions. Rapid progression, breathing trouble, fainting, inability to empty the bladder, or heart-rate changes require emergency care.

The symptoms of paraneoplastic polyneuropathy (PPN) are often more intense and progress more rapidly than common forms of nerve damage like those caused by diabetes. Because PPN is an immune-driven condition, it tends to follow a subacute timeline, meaning symptoms develop and worsen over a period of weeks to a few months, rather than many years [1][2].

Important Context: New, progressive imbalance, weakness, or autonomic symptoms deserve immediate medical assessment. However, these symptoms are not exclusively specific to paraneoplastic syndromes; they do not by themselves identify PPN and must be evaluated comprehensively.

Understanding the specific pattern, or phenotype, of your symptoms can help your medical team pinpoint the cause and determine how urgently to intervene.

Subacute Sensory Neuronopathy (SSN)

A characteristic pattern in PPN is subacute sensory neuronopathy (SSN), also known as sensory ganglionopathy [3]. Unlike typical neuropathy that starts in the toes and slowly moves up the legs, SSN is often “patchy” and unpredictable. (Note: SSN can also be caused by nonparaneoplastic issues like Sjögren’s disease or certain toxicities).

  • Loss of “Body Sense”: The hallmark of SSN is a loss of proprioception—your brain’s ability to know where your limbs are without looking at them [3]. This leads to sensory ataxia, a type of imbalance where you may feel unsteady or “drunk” while walking, especially in the dark [4][5].
  • Non-Length-Dependent: Symptoms may appear in your hands, arms, or even your face at the same time as your feet [6][7].
  • Pain and Tingling: You may experience sharp, burning pain (dysesthesia) or “pins and needles” (paresthesias) that can be quite severe [8][9].
  • Lack of Weakness: Pure SSN usually does not cause muscle weakness. If you can move your muscles normally but can’t coordinate your movements because you can’t “feel” your limbs, it raises suspicion for this specific phenotype [5].

Sensory, Motor, and Autonomic Symptoms

While SSN is a sensory-focused pattern, PPN can affect different parts of your nervous system:

  • Sensory: Changes in touch, pain, temperature, and balance [3].
  • Motor: Some forms of PPN involve mixed motor symptoms, causing actual muscle weakness, tripping, or difficulty lifting objects [10].
  • Autonomic: This involves the “automatic” functions of your body, like heart rate, blood pressure, and digestion [11].

Red Flags: When to Seek Emergency Care

In some cases, the immune attack affects the autonomic nervous system or motor nerves so severely that it becomes life-threatening. Call emergency services (911) or go to the nearest emergency department if you experience:

  • Difficulty Breathing: Sudden or rapidly worsening shortness of breath [12].
  • Severe Blood Pressure Drops: Feeling extremely dizzy, fainting, or actually losing consciousness when you stand up (orthostatic hypotension) [13][14].
  • Digestive Failure: Severe, persistent constipation, extreme abdominal swelling, or inability to keep food down, which may indicate intestinal pseudo-obstruction [15].
  • Urinary Retention: A sudden inability to empty your bladder despite feeling full [16].
  • Dangerous Heart Rate Instability: Palpitations, chest symptoms, or a heart rate that feels dangerously fast or slow while you are resting [17].
  • Rapidly Worsening Weakness: Sudden loss of muscle strength in your face, arms, or legs [12].

The Importance of Prompt Assessment

There is no universal “deadline” for nerve treatment, but earlier assessment and treatment may significantly improve the chance of stabilizing the condition [1]. Early diagnosis is critical because while treatments can often stop the immune system from causing further damage, they may not be able to reverse the loss of nerve cells that has already occurred [1]. If your symptoms are progressing quickly—changing week by week rather than month by month—it is vital to communicate this urgency to your neurology team promptly.

Common questions in this guide

What symptoms can paraneoplastic polyneuropathy cause?
Symptoms often develop over weeks to a few months and may include patchy sensory loss, burning pain or tingling, loss of balance, muscle weakness, or problems with blood pressure, digestion, bladder control, or heart rate. These symptoms can have causes other than paraneoplastic polyneuropathy, so they need a comprehensive medical evaluation.
What is sensory ganglionopathy, and how can it affect balance?
Sensory ganglionopathy, also called subacute sensory neuronopathy, affects nerve cells that carry information about limb position. Losing this “body sense” can cause sensory ataxia, which may feel like being unsteady or drunk, especially in the dark; symptoms may involve the hands, arms, face, and feet rather than starting only in the toes.
Can paraneoplastic polyneuropathy cause weakness or only sensory symptoms?
Some forms affect motor nerves and cause true muscle weakness, tripping, or difficulty lifting objects. Pure sensory neuronopathy usually does not cause weakness; a person may move normally but feel uncoordinated because they cannot sense where their limbs are.
What warning signs mean I need emergency care?
Call emergency services or go to an emergency department for trouble breathing, fainting or severe dizziness when standing, inability to empty the bladder, severe constipation with abdominal swelling or inability to keep food down, dangerous heart-rate changes, or rapidly worsening weakness. These symptoms can signal serious involvement of the nerves that control breathing, blood pressure, digestion, the bladder, or the heart.
How quickly can paraneoplastic polyneuropathy progress?
It often develops and worsens over weeks to a few months rather than over many years. Symptoms that change from week to week, especially rapidly worsening imbalance, weakness, or problems with automatic body functions, should be reported promptly to a neurology team.
Can treatment reverse nerve damage from paraneoplastic polyneuropathy?
Starting treatment early may improve the chance of stabilizing paraneoplastic polyneuropathy and stopping further immune-related damage. Treatment may not restore nerve cells that have already been lost, which is why rapidly progressing symptoms should be assessed promptly.

Get notified when new evidence is published on paraneoplastic polyneuropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies.

    Antoine JC, Robert-Varvat F, Maisonobe T, et al.

    Journal of the neurological sciences 2016; (361()):187-91.

    PMID: 26810539
  2. 2

    [Anti-Hu antibody positive sensory neuronopathy causing painful legs and moving toes (PLMT) in a 75-year-old female with small cell lung cancer (SCLC)].

    Tsujimoto Y, Hao A, Sato T, et al.

    Rinsho shinkeigaku = Clinical neurology 2018; (58(11)):677-681 doi:10.5692/clinicalneurol.cn-001198.

    PMID: 30369526
  3. 3

    [Acute sensory neuropathy associated with Hodgkin's lymphoma: a case study].

    Yokota Y, Mitsuke K, Minami H, et al.

    Rinsho shinkeigaku = Clinical neurology 2019; (59(6)):349-355 doi:10.5692/clinicalneurol.cn-001271.

    PMID: 31142709
  4. 4

    [A case of paraneoplastic sensory neuronopathy with anti-Hu antibody associated with large cell neuroendocrine carcinoma of the endometrium].

    Kato R, Aoyama N, Mizutani S, et al.

    Rinsho shinkeigaku = Clinical neurology 2020; (60(6)):441-445 doi:10.5692/clinicalneurol.60.cn-001393.

    PMID: 32435048
  5. 5

    Sensory neuronopathies: new genes, new antibodies and new concepts.

    Fargeot G, Echaniz-Laguna A

    Journal of neurology, neurosurgery, and psychiatry 2021; doi:10.1136/jnnp-2020-325536.

    PMID: 33563795
  6. 6

    [Sensory neuronopathy. Its recognition and early treatment].

    Zuberbuhler P, Young P, León Cejas LV, et al.

    Medicina 2015; (75(5)):297-302.

    PMID: 26502464
  7. 7

    Anti-Yo related pure sensory ganglionopathy: a rare paraneoplastic entity.

    Theologou R, Tsechelidis I, Artemiadis A, et al.

    Acta neurologica Belgica 2026; (126(4)):1471-1474 doi:10.1007/s13760-026-03115-8.

    PMID: 42287493
  8. 8

    Sensory neuronopathies: A case series and literature review.

    Sancho Saldaña A, Mahdi-Rogers M, Hadden RD

    Journal of the peripheral nervous system : JPNS 2021; (26(1)):66-74 doi:10.1111/jns.12433.

    PMID: 33491284
  9. 9

    Small Cell Lung Cancer Accompanied by Tonsillar Metastasis and Anti-Hu Antibody-Associated Paraneoplastic Neuropathy: A Rare Case Report With Long-Term Survival.

    Ni J, Weng L, Liu M, et al.

    Medicine 2015; (94(50)):e2291 doi:10.1097/MD.0000000000002291.

    PMID: 26683964
  10. 10

    Rapidly Progressive Paraneoplastic Neuropathy Associated with Renal Cell Carcinoma: A Case Report.

    Shah D, Trivedi J, Vernino S, Khan S

    Journal of cancer science and clinical therapeutics 2022; (6(3)):333-335 doi:10.26502/jcsct.5079171.

    PMID: 36685138
  11. 11

    Autonomic nervous system involvement in autoimmune encephalitis and paraneoplastic neurological syndromes.

    Villagrán-García M, Farina A, Campetella L, et al.

    Revue neurologique 2024; (180(1-2)):107-116 doi:10.1016/j.neurol.2023.12.001.

    PMID: 38142198
  12. 12

    Guillain-Barré syndrome.

    Willison HJ, Jacobs BC, van Doorn PA

    Lancet (London, England) 2016; (388(10045)):717-27.

    PMID: 26948435
  13. 13

    Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.

    de Rojas Leal C, Lage-Sánchez JM, Pinel-Ríos J, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(8)):4841-4845 doi:10.1007/s10072-022-06075-y.

    PMID: 35482157
  14. 14

    A Case Report of Pediatric Paraneoplastic Dysautonomia.

    Harer K, Mann J, Muhlbauer N, et al.

    Pediatric emergency care 2020; (36(12)):e742-e744 doi:10.1097/PEC.0000000000001558.

    PMID: 30045352
  15. 15

    MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature Review.

    Ricigliano VAG, Fossati B, Saraceno L, et al.

    Frontiers in neuroscience 2018; (12()):17 doi:10.3389/fnins.2018.00017.

    PMID: 29416500
  16. 16

    Dysautonomia associated with immune checkpoint inhibitors.

    Tezuka T, Okuzumi S, Nakashima C, et al.

    Journal of neurology 2023; (270(7)):3413-3423 doi:10.1007/s00415-023-11667-5.

    PMID: 36939931
  17. 17

    Cardiac Involvement in Peripheral Neuropathies.

    Burakgazi AZ, AlMahameed S

    Journal of clinical neuromuscular disease 2016; (17(3)):120-8 doi:10.1097/CND.0000000000000106.

    PMID: 26905912

This page is for informational purposes only and does not constitute medical advice. New or rapidly worsening symptoms should be assessed promptly; seek emergency care for breathing trouble, fainting, urinary retention, severe digestive symptoms, dangerous heart-rate changes, or rapidly worsening weakness.